🎙In our latest episode of Running Through Walls, Rhythm Pharmaceuticals CFO Hunter Smith speaks with Nimish Shah about managing the financial backbone of a company changing the lives of patients. Tune in for insights on succeeding as a public healthcare company. bit.ly/4hTWGmx

Turns out neither #foundermode nor #managermode are popular with our industry friends. Our 9th annual #HealthcarePrognosis uncovered their least favorite things about both: bit.ly/4jbjptq

Check out the top four things our #HealthcarePrognosis respondents expect from tariffs (spoiler alert: not great things!): bit.ly/4jbjptq

We are thrilled to welcome longtime friend of the firm Siobhan Nolan Mangini to our partnership. Siobhan’s experience scaling & building healthcare companies will be invaluable as we continue to invest in founders building transformative companies. vnrk.co/4kfRwl8

Every industry will see massive shifts from #AI and #healthcare is no exception. 60%+ of the folks we asked think it’ll add 5+ points to the bottom line for companies who integrate it. Do you agree? #HealthcarePrognosis bit.ly/4jbjptq

Our 9th annual Healthcare Prognosis projects a lot of uncertainty in our future, so we turned to our experts @brobertsvc.bsky.social and @bobkocher.bsky.social to share their candid reactions and thoughts in a special Running Through Walls conversation. vnrk.co/3FgJVUq

🎙️We’re back with an AI-focused episode of #RunningThroughWalls! @bobkocher.bsky.social and Punit Soni of Suki discuss how #AI in healthcare is solving significant issues and accelerating the adoption of new technology in a notoriously slow industry. Listen here: bit.ly/42OSgrq

🎙In our latest episode of #RunningThroughWalls, Charlie Glazer of Jefferies chats with Nimish Shah about what makes a great healthcare team and deal and why value will always be more important than valuation. For more insights, listen here: vnrk.co/3DqNfvj

Check out the newest Venture Unlocked podcast episode, where @vcsurferdad.bsky.social sat down with Samir Kaji to discuss his journey from product management to Venrock, how Venrock maintains our competitive edge in technology and healthcare, and more. vnrk.co/3Q8Yds1

🎙We’re back with the latest #RunningThroughWalls conversation between CEO of Crescent Biopharma Jonathan Violin and Venrock partner Nimish Shah on how Crescent is building a new class of drugs while preparing for the public markets. Listen here: vnrk.co/40MHeR7

🎙On the latest episode of #RunningThroughWalls, Nimish Shah talks to CEO of Spyre Therapeutics Cameron Turtle about what’s ahead for their most promising molecules in 2025 and his perspective on building collaborative teams and Boards. Listen here: vnrk.co/3PAJllS #JPM2025

🎙On the latest episode of #RunningThroughWalls, Bruce Perkins, the architect of Humana’s Medicare Advantage franchise, shares with @bobkocher.bsky.social and @brobertsvc.bsky.social his lessons learned and perspective on what’s ahead for the healthcare industry. Listen here: vnrk.co/3ZLtBRT